International Flavors & Fragrances IFF Health & Biosciences — Selling and administrative expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by International Flavors & Fragrances in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: International Flavors & Fragrances’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about International Flavors & Fragrances's health & biosciences — selling and administrative expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is International Flavors & Fragrances's health & biosciences — selling and administrative expenses?
- International Flavors & Fragrances (IFF) reported health & biosciences — selling and administrative expenses of $92M in Q1 2026.
- How has International Flavors & Fragrances's health & biosciences — selling and administrative expenses changed year-over-year?
- International Flavors & Fragrances's health & biosciences — selling and administrative expenses increased by 13.6% year-over-year, from $81M to $92M.
- What is the long-term trend for International Flavors & Fragrances's health & biosciences — selling and administrative expenses?
- Over 3 years (2022 to 2025), International Flavors & Fragrances's health & biosciences — selling and administrative expenses has grown at a 7.3% compound annual growth rate (CAGR), from $282M to $348M.
- What does health & biosciences — selling and administrative expenses mean?
- Operating costs related to the sales, marketing, and general administration of the Health & Biosciences segment. This includes salaries for non-manufacturing staff, advertising, and corporate overhead allocated to the segment.